Addex Therapeutics Ltd
ADXN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,577 | -$1,841 | -$1,473 | -$1,206 |
| Dep. & Amort. | $2 | $2 | $2 | $24 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $31 |
| Change in WC | $143 | $74 | -$17 | $438 |
| Other Non-Cash | $898 | $1,345 | $889 | $689 |
| Operating Cash Flow | -$533 | -$420 | -$599 | -$24 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $60 | $0 | $0 | -$16 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$737 | $0 | $0 |
| Investing Cash Flow | $60 | -$737 | $0 | -$16 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$2 | -$2 | -$2 | -$2 |
| Stock Issued | $366 | $0 | $100 | $241 |
| Stock Repurch. | -$3 | -$26 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1 | $677 | -$1 | -$241 |
| Financing Cash Flow | $361 | $649 | $98 | -$2 |
| Forex Effect | -$2 | -$16 | -$16 | $34 |
| Net Chg. in Cash | -$114 | -$524 | -$516 | -$7 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,301 | $2,825 | $3,342 | $3,349 |
| End Cash | $2,187 | $2,301 | $2,825 | $3,342 |
| Free Cash Flow | -$533 | -$420 | -$599 | -$24 |